ACTICON- dexbrompheniramine maleate, pseudoephedrine hydrochloride tablet 
Actipharma, Inc

----------

ACTICON® COLD & ALLERGY Tablets

Drug Facts

Active ingredients (in each tablet)

Dexbrompheniramine Maleate, USP 2 mg
Pseudoephedrine HCl, USP 60 mg

Purpose

Antihistamine
Nasal Decongestant

Uses

Temporarily relieves these symptoms due to the common cold, hay fever (allergic rhinitis) or other upper respiratory allergies:
• runny nose • sneezing
• itching of the nose or throat
• itchy, watery eyes
• nasal congestion
• reduces swelling of nasal passages

Warnings

Do not exceed recommended dosage.

Do not use
• if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product

Ask a doctor before use if you have
• a breathing problem such as emphysema or chronic bronchitis
• glaucoma • heart disease
• high blood pressure
• thyroid disease
• diabetes mellitus
• difficulty in urination due to enlargement of the prostate gland

Do not take this product if you are taking sedatives or tranquilizers, without first consulting your doctor.

When using this product
• excitability may occur, especially in children
• may cause drowsiness
• alcohol, sedatives and tranquilizers may increase drowsiness
• avoid alcoholic beverages
• use caution when driving a motor vehicle or operating machinery

Stop use and ask a doctor if
• nervousness, dizziness, or sleeplessness occur
• if symptoms do not improve within 7 days or are accompanied by fever
• new symptoms occur

If pregnant or breast feeding, ask a health professional before use.

Keep out of reach of children. In case of accidental overdose, seek professional help or contact a Poison Control Center immediately.

Directions

Do not exceed recommended dosage.

Adults and children 12 years of age and over:1 tablet every 4 to 6 hours not to exceed 4 tablets in 24 hours or as directed by a doctor
Children 6 to under 12 years of age:1/2 tablet every 4 to 6 hours not to exceed 2 tablets in 24 hours or as directed by a doctor
Children under
6 years of age
Consult a doctor

Other information

Store at 15°-30°C (59°-86°F) [see USP Controlled Room Temperature].

Inactive ingredients

Magnesium stearate, microcrystalline cellulose, sodium starch glycolate

Questions or Comments?

call weekdays from 8AM to 4PM AST at 1.787.608.0882

Contains the same active ingredients as Conex® Tablets*

Tamper evident by foil seal under cap.
Do not use if foil seal is broken or missing.

Manufactured in USA with imported ingredients for ActiPharma, Inc. San Juan, PR 00917.  www.actipharma.net

*Conex® Tablets is a registered trademark of Llorens Pharmaceutical Corp. This product is not manufactured, distributed or marketed by Llorens Pharmaceutical Corp.

Packaging

ACTICON-401

ACTICON 
dexbrompheniramine maleate, pseudoephedrine hydrochloride tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:63102-401
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
DEXBROMPHENIRAMINE MALEATE (UNII: BPA9UT29BS) (DEXBROMPHENIRAMINE - UNII:75T64B71RP) DEXBROMPHENIRAMINE MALEATE2 mg
PSEUDOEPHEDRINE HYDROCHLORIDE (UNII: 6V9V2RYJ8N) (PSEUDOEPHEDRINE - UNII:7CUC9DDI9F) PSEUDOEPHEDRINE HYDROCHLORIDE60 mg
Inactive Ingredients
Ingredient NameStrength
MAGNESIUM STEARATE (UNII: 70097M6I30)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)  
Product Characteristics
ColorwhiteScore2 pieces
ShapeOVALSize13mm
FlavorImprint Code A401
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:63102-401-6060 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product08/13/2015
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01208/13/2015
Labeler - Actipharma, Inc (079340948)

Revised: 10/2023
Document Id: 46d93bc7-2741-4f41-8cb9-3b31ee8b5804
Set id: 847014ab-86ae-40c5-8e7f-f1ddea14f1b3
Version: 4
Effective Time: 20231004
 
Actipharma, Inc